241 related articles for article (PubMed ID: 10941248)
21. Managing oncology costs.
Reeder CE; Gordon D
Am J Manag Care; 2006 Feb; 12(1 Suppl):S3-16; quiz S17-9. PubMed ID: 16478368
[TBL] [Abstract][Full Text] [Related]
22. Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
Garrison LP
Oncologist; 2010; 15 Suppl 1():49-57. PubMed ID: 20237218
[No Abstract] [Full Text] [Related]
23. Seeking value as cancer drug costs soar.
Bender E
Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
[TBL] [Abstract][Full Text] [Related]
24. Perspectives on Cost and Value in Cancer Care.
Saltz LB
JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
[No Abstract] [Full Text] [Related]
25. Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians.
de Kort SJ; Kenny N; van Dijk P; Gevers S; Richel DJ; Willems DL
Eur J Cancer; 2007 Sep; 43(13):1983-9. PubMed ID: 17616456
[TBL] [Abstract][Full Text] [Related]
26. [Innovative therapy, early and cost-benefit assessment].
Dierks C
Onkologie; 2012; 35 Suppl 2():7. PubMed ID: 22517064
[No Abstract] [Full Text] [Related]
27. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
28. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
Moatti JP
Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
[TBL] [Abstract][Full Text] [Related]
29. Economic analysis of cancer treatment costs: another tool for oncology managers.
Chirikos TN; Ruckdeschel JC; Krischer JP
J Oncol Manag; 2001; 10(3):11-7. PubMed ID: 11548179
[TBL] [Abstract][Full Text] [Related]
30. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD
J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
[No Abstract] [Full Text] [Related]
31. Minimalism in oncology.
The Lancet Oncology
Lancet Oncol; 2018 May; 19(5):579. PubMed ID: 29726372
[No Abstract] [Full Text] [Related]
32. The shortage of essential chemotherapy drugs in the United States.
Gatesman ML; Smith TJ
N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
[No Abstract] [Full Text] [Related]
33. An economic model to reduce the cost of chemotherapy for gynecologic cancer.
Jacobs VR; Thoedtmann J; Brunner B; Kiechle M
Int J Fertil Womens Med; 2004; 49(6):274-7. PubMed ID: 15751266
[TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness in oncology.
Lancet; 1986 Feb; 1(8476):325. PubMed ID: 2868189
[No Abstract] [Full Text] [Related]
35. [Cost of medications in the oncology sector in the context of health economics].
Walter E; Batista A
Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
[TBL] [Abstract][Full Text] [Related]
36. Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.
Drummond M; Evans B; LeLorier J; Karakiewicz P; Martin D; Tugwell P; MacLeod S
Can J Clin Pharmacol; 2009; 16(2):e273-81; discussion e282-4. PubMed ID: 19439771
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of Anti-cancer Therapies with Reimbursement Limited to Comprehensive Cancer Centres Using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale].
Büchler T; Melichar B; Vrána D; Lemstrová R; Fínek J; Dušek L; Petráková K; Prausová J
Klin Onkol; 2017; 30(5):349-360. PubMed ID: 29031037
[TBL] [Abstract][Full Text] [Related]
38. Inequalities in oncology care: Economic consequences of high cost drugs.
Niezen MG; Stolk EA; Steenhoek A; Uyl-De Groot CA
Eur J Cancer; 2006 Nov; 42(17):2887-92. PubMed ID: 16979891
[TBL] [Abstract][Full Text] [Related]
39. Economic evaluation in radiology: reviewing the literature and examples in oncology.
Bresnahan BW
Acad Radiol; 2010 Sep; 17(9):1090-5. PubMed ID: 20634104
[TBL] [Abstract][Full Text] [Related]
40. Value in Oncology: It Is in the Eyes of the Beholder.
Nabhan C; Phillips EG; Feinberg BA
J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
